The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis

BACKGROUND: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS). METHODS: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasirzadeh, Amirreza, Jahanshahi, Reza, Ghajarzadeh, Mahsa, Mohammadi, Aida, Moghadasi, Abdorreza Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580199/
https://www.ncbi.nlm.nih.gov/pubmed/37854988
http://dx.doi.org/10.4103/ijpvm.ijpvm_44_22
_version_ 1785121896689303552
author Nasirzadeh, Amirreza
Jahanshahi, Reza
Ghajarzadeh, Mahsa
Mohammadi, Aida
Moghadasi, Abdorreza Naser
author_facet Nasirzadeh, Amirreza
Jahanshahi, Reza
Ghajarzadeh, Mahsa
Mohammadi, Aida
Moghadasi, Abdorreza Naser
author_sort Nasirzadeh, Amirreza
collection PubMed
description BACKGROUND: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS). METHODS: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched for references of the included studies, and conference abstracts that were published up to September 2021. RESULTS: The literature search revealed 5719 articles, after deleting duplicates 3616 remained. Finally, 17 studies were included. The pooled prevalence of IBD in MS was 1% (I(2) = 96.3%, P < 0.001). The pooled odds ratio of developing IBD in MS cases was 1.36 (95% CI: 1.1–1.6) (I(2) = 58.3, P = 0.01). CONCLUSIONS: The results of this systematic review and meta-analysis show that the pooled prevalence of IBD in MS patients was 1% and the pooled odds ratio of developing IBD in MS cases was 1.36.
format Online
Article
Text
id pubmed-10580199
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-105801992023-10-18 The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis Nasirzadeh, Amirreza Jahanshahi, Reza Ghajarzadeh, Mahsa Mohammadi, Aida Moghadasi, Abdorreza Naser Int J Prev Med Review Article BACKGROUND: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS). METHODS: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched for references of the included studies, and conference abstracts that were published up to September 2021. RESULTS: The literature search revealed 5719 articles, after deleting duplicates 3616 remained. Finally, 17 studies were included. The pooled prevalence of IBD in MS was 1% (I(2) = 96.3%, P < 0.001). The pooled odds ratio of developing IBD in MS cases was 1.36 (95% CI: 1.1–1.6) (I(2) = 58.3, P = 0.01). CONCLUSIONS: The results of this systematic review and meta-analysis show that the pooled prevalence of IBD in MS patients was 1% and the pooled odds ratio of developing IBD in MS cases was 1.36. Wolters Kluwer - Medknow 2023-06-22 /pmc/articles/PMC10580199/ /pubmed/37854988 http://dx.doi.org/10.4103/ijpvm.ijpvm_44_22 Text en Copyright: © 2023 International Journal of Preventive Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Nasirzadeh, Amirreza
Jahanshahi, Reza
Ghajarzadeh, Mahsa
Mohammadi, Aida
Moghadasi, Abdorreza Naser
The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title_full The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title_fullStr The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title_full_unstemmed The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title_short The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
title_sort prevalence of inflammatory bowel disease (ibd) in patients with multiple sclerosis (ms): a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580199/
https://www.ncbi.nlm.nih.gov/pubmed/37854988
http://dx.doi.org/10.4103/ijpvm.ijpvm_44_22
work_keys_str_mv AT nasirzadehamirreza theprevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT jahanshahireza theprevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT ghajarzadehmahsa theprevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT mohammadiaida theprevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT moghadasiabdorrezanaser theprevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT nasirzadehamirreza prevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT jahanshahireza prevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT ghajarzadehmahsa prevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT mohammadiaida prevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis
AT moghadasiabdorrezanaser prevalenceofinflammatoryboweldiseaseibdinpatientswithmultiplesclerosismsasystematicreviewandmetaanalysis

Ejemplares similares